Thesis Defense Announcement
To:  The George Mason University Community
Candidate: Heather Hobbs

Program: M.S. in Biology



Date:   Friday July 20, 2018

Time:   12:00 Noon

Place:  IABR, Room 1004
             George Mason University
             Science & Tech Campus<http://www.gmu.edu/resources/welcome/Directions-to-GMU.html>




Title: "The Role of Vesicular Transport through Exosomal Exchange in the Pathogenesis of Burkholderia pseudomallei"

Committee Chair: Dr. Ramin Hakami
Committee Members: Dr. Monique van Hoek, Dr. Emanuel Petricoin III

This is a public defense and all are invited to attend.



Abstract:
Exosomes are extracellular vesicles that play a central role in intercellular communication. They have recently attracted much attention as their critical function in a variety of disease, including infectious diseases, has become better understood. However, there are significant gaps in our knowledge regarding how exosomes derived from an infectious origin (EXi) can alter host innate immunity. Using our model of purifying exosomes from Burkholderia pseudomallei (Bp) infected cells, we aimed to better understand the role host exosomes play in the pathogenesis of Bp, a Category B priority pathogen that possess significant risk to public health and for which we currently have no effective countermeasures. We have shown that EXi induce human monocytes to differentiate into macrophage-like cells and stimulate the release of IL-2, IL-6, and TNF-a. Additionally, we have demonstrated that EXi promote increased bacterial clearance in treated naïve monocytes, and experiments are under way to elucidate the exact mechanisms. We have also analyzed the protein complements of the EXi and EXu by mass spectrometry analysis. Collectively, our data support a model in which the EXi prime local and distal naïve cells to mount a more effective response against Bp. These findings provide insights into a previously unexplored aspect of host response to infection, which can aid in future development of novel vaccines or therapeutics against bacterial pathogens.

###